Dr. Raeman is an Associate Professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and a core member of Pittsburgh Liver Research Center. Dr. Raeman earned his MS from Clemson University, PhD from the University of Georgia and completed his postdoctoral training at Emory University School of Medicine. Dr. Raeman specializes in delineating the cellular and molecular mechanisms of chronic liver diseases, specifically focusing on the role of gut-liver-immune axis in chronic liver disease progression. The current research in Dr.

Dr Akash Shukla from Mumbai, India has core area of interest is portal hypertension, complications of cirrhosis and vascular liver disorders. He's the first author on the APASL guidelines for management of Budd Chiari syndrome and recently published APASL Guidelines updates on NCPF / IPH. He was also on the steering committee of VALDIG, EASL and part of Baveno 7 panel.

Dr. Gerald Scott Winder is a Senior Staff Physician in the Departments of Psychiatry and Surgery at Henry Ford Health in Detroit, MI and a Clinical Professor of Psychiatry at Michigan State University. He holds a medical degree from the University of Utah School of Medicine and a Masters of Science degree from the University of Michigan School of Public Health. He is a fellow in the Academy of Consultation-Liaison Psychiatry. He completed a general psychiatry residency and a consultation-liaison psychiatry fellowship at the University of Michigan.

Professor of Hepatology at Department of Gastroenterology and Hepatology, Odense University Hospital and University of Southern Denmark. ORCID id: https://orcid.org/0000-0003-1854-1924<br><br>I work to reduce morbidity and mortality from alcohol-related liver disease and steatotic liver disease. My research centers on biomarker development and validation, with a particular focus on early disease detection, cost-effective referral pathways, and omics technologies.

Dr. El-Serag obtained his medical degree from Al-Arab Medical University in Libya, completed his internship and residency in internal medicine (1995) at Greenwich Hospital, Yale University, Connecticut, and completed a fellowship in gastroenterology (1997) at the University of New Mexico, Albuquerque, New Mexico, where he also earned a master's degree in public health (1998). In 1999, Dr. El-Serag joined the Michael E. DeBakey VA Medical Center and Baylor College of Medicine (BCM) in Houston, where he later became Chief of the Section of Gastroenterology & Hepatology (2007-2016).

Gen-Sheng Feng is Professor of Pathology and Molecular Biology at the University of California, San Diego. His research program aims at understanding cross-talks and regulation of signaling pathways in different cell types in health and disease, which was initiated by his discovery of an SH2-containing tyrosine phosphatase Shp2 (originally called Syp) in his postdoc studies with the late Tony Pawson. In the past three decades, his lab is in the driver's position to decipher how Shp2 promotes signaling through the RTK-Ras-Erk pathway.

Catherine Lucey is a White House Correspondent for Bloomberg News.<br>Based in Washington, she has covered the White House and national politics for nearly 20 years. Her reporting has taken her across the country and around the world, with stops in Europe, Asia and South America during President Donald Trump's first term and to the Middle East, India and Ireland with President Joe Biden.<br>Prior to joining Bloomberg, Lucey worked for the Wall Street Journal and the Associated Press.

I am a hepatologist and clinician scientist at Baylor College of Medicine. My clinical research focuses on the intersection on alcohol-related liver injury and metabolic dysfunction and the impact on liver outcomes including liver cancer.

Dr. Christine Hsu is a transplant hepatologist, assistant research physician and staff clinician at National Institute of Diabetes and Digestive and Kidney Diseases at National Institute of Health. She also has a adjunct faculty position at Georgetown University. Her research interests are aimed at improving outcomes of alcohol associated liver disease and hepatocellular carcinoma. She was one of the original principal investigators on ACCELERATE-AH, which is a multi-centered consortium to evaluate outcomes of early liver transplant in patients with alcohol-associated liver disease.

Samantha Kimbrough, MSN, APRN, AGNP-C, is a board-certified nurse practitioner specializing in liver transplant medicine at UT Southwestern Medical Center. Mrs. Kimbrough earned her Bachelor of Science in Nursing from Bellarmine University in Louisville, Kentucky and her Master of Science in Nursing from the University of Cincinnati in Cincinnati, Ohio. She began her nursing career in 2011 as a surgical/trauma ICU nurse at the University of Louisville Hospital in Louisville, Kentucky. In 2017, Mrs.